- Home
- LGVN vs AMST Comparison
LGVN vs AMST Comparison
Compare LGVN & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- AMST
- Stock Information
- Founded
- LGVN 2014
- AMST 2017
- Country
- LGVN United States
- AMST United States
- Employees
- LGVN N/A
- AMST N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- AMST Computer Software: Prepackaged Software
- Sector
- LGVN Health Care
- AMST Technology
- Exchange
- LGVN Nasdaq
- AMST Nasdaq
- Market Cap
- LGVN 16.6M
- AMST 13.3M
- IPO Year
- LGVN 2021
- AMST 2020
- Fundamental
- Price
- LGVN $0.79
- AMST $3.63
- Analyst Decision
- LGVN Strong Buy
- AMST
- Analyst Count
- LGVN 2
- AMST 0
- Target Price
- LGVN $6.50
- AMST N/A
- AVG Volume (30 Days)
- LGVN 496.8K
- AMST 2.1M
- Earning Date
- LGVN 11-11-2025
- AMST 11-13-2025
- Dividend Yield
- LGVN N/A
- AMST N/A
- EPS Growth
- LGVN N/A
- AMST N/A
- EPS
- LGVN N/A
- AMST N/A
- Revenue
- LGVN $2,073,000.00
- AMST $82,544.00
- Revenue This Year
- LGVN N/A
- AMST N/A
- Revenue Next Year
- LGVN N/A
- AMST N/A
- P/E Ratio
- LGVN N/A
- AMST N/A
- Revenue Growth
- LGVN 68.67
- AMST N/A
- 52 Week Low
- LGVN $0.63
- AMST $2.00
- 52 Week High
- LGVN $2.48
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- LGVN 37.95
- AMST 67.89
- Support Level
- LGVN $0.78
- AMST $2.62
- Resistance Level
- LGVN $0.85
- AMST $4.78
- Average True Range (ATR)
- LGVN 0.05
- AMST 0.25
- MACD
- LGVN 0.02
- AMST 0.11
- Stochastic Oscillator
- LGVN 46.30
- AMST 47.25
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.